Testing the Addition of an Anti-cancer Drug, M3814, to the Usual Treatment (Mitoxantrone, Etoposide, and Cytarabine) for Relapsed or Refractory Acute Myeloid Leukemia
National Cancer Institute (NCI)
National Cancer Institute (NCI)
St. Jude Children's Research Hospital
National Cancer Institute (NCI)
Genmab
Emory University
Merck Sharp & Dohme LLC
St. Jude Children's Research Hospital
St. Jude Children's Research Hospital
St. Jude Children's Research Hospital
City of Hope Medical Center
Medical College of Wisconsin
National Institutes of Health Clinical Center (CC)
Alliance for Clinical Trials in Oncology